Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
Champions Oncology (NASDAQ:CSBR), a global preclinical and clinical research services provider specializing in oncology solutions, has scheduled its third quarter fiscal 2025 financial results announcement for Tuesday, March 11, 2025, after market close.
The company will host a conference call at 4:30 P.M. EDT to discuss the results for the quarter ended January 31, 2025. Investors can join via phone using the access code 403045: Domestic (888-506-0062) or International (973-528-0011). A replay will be available through phone or the company's website investor section within 72 hours using passcode 52158.
Champions Oncology (NASDAQ:CSBR), un fornitore globale di servizi di ricerca preclinica e clinica specializzato in soluzioni oncologiche, ha programmato l'annuncio dei risultati finanziari del terzo trimestre fiscale 2025 per martedì 11 marzo 2025, dopo la chiusura del mercato.
L'azienda ospiterà una conferenza telefonica alle 16:30 EDT per discutere i risultati del trimestre conclusosi il 31 gennaio 2025. Gli investitori possono partecipare telefonicamente utilizzando il codice di accesso 403045: Nazionale (888-506-0062) o Internazionale (973-528-0011). Una registrazione sarà disponibile tramite telefono o nella sezione investitori del sito web dell'azienda entro 72 ore utilizzando il codice di accesso 52158.
Champions Oncology (NASDAQ:CSBR), un proveedor global de servicios de investigación preclínica y clínica especializado en soluciones oncológicas, ha programado el anuncio de sus resultados financieros del tercer trimestre fiscal 2025 para el martes 11 de marzo de 2025, después del cierre del mercado.
La empresa llevará a cabo una conferencia telefónica a las 4:30 P.M. EDT para discutir los resultados del trimestre que finalizó el 31 de enero de 2025. Los inversores pueden unirse por teléfono utilizando el código de acceso 403045: Nacional (888-506-0062) o Internacional (973-528-0011). Una grabación estará disponible a través del teléfono o en la sección de inversores del sitio web de la empresa dentro de las 72 horas usando el código de acceso 52158.
Champions Oncology (NASDAQ:CSBR)는 종양학 솔루션을 전문으로 하는 글로벌 전임상 및 임상 연구 서비스 제공업체로, 2025 회계연도 3분기 재무 결과 발표를 2025년 3월 11일 화요일, 시장 마감 후로 예정했습니다.
회사는 오후 4:30 EDT에 2025년 1월 31일에 종료된 분기의 결과를 논의하기 위한 전화 회의를 개최합니다. 투자자는 액세스 코드 403045를 사용하여 전화로 참여할 수 있습니다: 국내 (888-506-0062) 또는 국제 (973-528-0011). 72시간 이내에 52158 비밀번호를 사용하여 전화 또는 회사 웹사이트의 투자자 섹션을 통해 재생이 가능합니다.
Champions Oncology (NASDAQ:CSBR), un fournisseur mondial de services de recherche préclinique et clinique spécialisé dans les solutions oncologiques, a programmé l'annonce de ses résultats financiers du troisième trimestre de l'exercice 2025 pour mardi 11 mars 2025, après la clôture du marché.
La société animera une conférence téléphonique à 16h30 EDT pour discuter des résultats du trimestre clos le 31 janvier 2025. Les investisseurs peuvent rejoindre par téléphone en utilisant le code d'accès 403045 : National (888-506-0062) ou International (973-528-0011). Un enregistrement sera disponible par téléphone ou dans la section investisseurs du site Web de l'entreprise dans les 72 heures en utilisant le code d'accès 52158.
Champions Oncology (NASDAQ:CSBR), ein globaler Anbieter von präklinischen und klinischen Forschungsdienstleistungen, der sich auf Onkologielösungen spezialisiert hat, hat die Bekanntgabe seiner finanziellen Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 für Dienstag, den 11. März 2025, nach Börsenschluss angesetzt.
Das Unternehmen wird um 16:30 Uhr EDT eine Telefonkonferenz abhalten, um die Ergebnisse für das am 31. Januar 2025 endende Quartal zu besprechen. Investoren können telefonisch teilnehmen, indem sie den Zugangscode 403045 verwenden: Inland (888-506-0062) oder International (973-528-0011). Eine Aufzeichnung wird innerhalb von 72 Stunden über das Telefon oder den Investorenbereich der Unternehmenswebsite unter Verwendung des Zugangscodes 52158 verfügbar sein.
- None.
- None.
HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the third quarter ended January 31, 2025, on Tuesday, March 11, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 403045. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode:52158, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Rachel Bunting, MS, MBA
VP, Global Marketing
Marketing@ChampionsOncology.com
Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Champions Oncology (CSBR) release Q3 2025 earnings?
What time is Champions Oncology (CSBR) Q3 2025 earnings call?
How can investors access CSBR's Q3 2025 earnings call?
How can investors access the replay of CSBR's Q3 2025 earnings call?
